Clinical Trials Directory

Trials / Completed

CompletedNCT02822625

Efficacity of a Standardized Hypnotic Message During the Application of a Qutenza (Capsaicin) 8% Patch

Efficacity of a Standardized Hypnotic Message on Pain Experienced During the Application of a Qutenza (Capsaicin) 8% Patch in Patients With Peripheral Neuropathic Pain

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
69 (actual)
Sponsor
Institut de Cancérologie de Lorraine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

QUTENZA® is a skin patch with a high concentration of capsaicin (8%) which is the component responsible for spicy peppers. QUTENZA® is indicated for the treatment of peripheral neuropathic pain in non-diabetic adults either alone or in combination with other analgesics. Acute pain experienced during and after the procedure can be relieved by local cooling methods and oral analgesics but the pain remains intense. The hypothesis is that hypnosis via a standardized hypnotic message would increase the local tolerance of the treatment when applying the patch QUTENZA®. To date, there are no studies that can confirm or refute this hypothesis.

Conditions

Interventions

TypeNameDescription
DRUGQUTENZA®
OTHERhypnotic message
OTHERmusic therapy

Timeline

Start date
2016-08-30
Primary completion
2019-07-10
Completion
2019-07-13
First posted
2016-07-04
Last updated
2022-04-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02822625. Inclusion in this directory is not an endorsement.